---
title: "GlucoTrack surges 13% on Lokahi Therapeutics merger"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292802318.md"
description: "GCTK.US jumps 13% to $0.6005 on merger completion, volume hits 57.3M shares"
datetime: "2026-07-15T17:51:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292802318.md)
  - [en](https://longbridge.com/en/news/292802318.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292802318.md)
---

# GlucoTrack surges 13% on Lokahi Therapeutics merger

GlucoTrack(GCTK.US) 盘中涨**13.49%**，现报**0.6005 美元**。公司已完成与 Lokahi Therapeutics 的战略合并。

成交量达**5732.98 万股**，市场交投活跃。

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [GlucoTrack to issue 2,505,513 unregistered shares to White Lion Capital under stock purchase agreement amendment](https://longbridge.com/en/news/295445026.md)
- [GlucoTrack announces special shareholder meeting](https://longbridge.com/en/news/294556297.md)
- [GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab to 12 university partnerships](https://longbridge.com/en/news/294509720.md)
- [GlucoTrack amends 8-K to update terms of $900,000 note-for-shares exchange agreement](https://longbridge.com/en/news/294265766.md)
- [Glucotrack Merges With Lokahi Therapeutics; Former Holders to Own 90% Post-Conversion](https://longbridge.com/en/news/292819350.md)